1928:TSESands China Ltd. Analysis
Data as of 2026-07-06 - not real-time
¥3,499.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Sekisui House posted a solid first‑quarter earnings beat with sales of ¥908.9 bn and net income of ¥58.5 bn, driving EPS up to ¥396.86 – a clear improvement over the prior year. Revenue grew modestly at 1.7% YoY and margins remain healthy (gross 20.4%, operating 8.4%, profit 6.1%), supporting a low trailing P/E of 8.8× and a price‑to‑book of just 1.05. The company also offers an attractive 4.24% dividend yield with a payout ratio below 40%, indicating sustainable income for shareholders. However, the balance sheet shows a high debt‑to‑equity ratio of ~85%, which tempers the optimism despite a sizable cash pile of ¥296 bn.
Technically, the stock trades at ¥3,499, just below the identified resistance of ¥3,512 and above the support of ¥3,202, while the 20‑day SMA (¥3,317) lies well beneath the current price, suggesting short‑term momentum. The MACD is bullish and the histogram is robust, yet the broader trend is flagged as bearish and volume is decreasing, hinting at possible consolidation. RSI sits at 66.7, approaching overbought territory, and 30‑day volatility is elevated at 21.7%, reflecting heightened price swings. The Fear‑Greed Index reads “Extreme Greed,” pointing to strong investor appetite, while the upside‑downside projection shows roughly a 9.7% upside potential toward the median analyst target of ¥3,900.
Technically, the stock trades at ¥3,499, just below the identified resistance of ¥3,512 and above the support of ¥3,202, while the 20‑day SMA (¥3,317) lies well beneath the current price, suggesting short‑term momentum. The MACD is bullish and the histogram is robust, yet the broader trend is flagged as bearish and volume is decreasing, hinting at possible consolidation. RSI sits at 66.7, approaching overbought territory, and 30‑day volatility is elevated at 21.7%, reflecting heightened price swings. The Fear‑Greed Index reads “Extreme Greed,” pointing to strong investor appetite, while the upside‑downside projection shows roughly a 9.7% upside potential toward the median analyst target of ¥3,900.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near resistance with decreasing volume
- Bearish trend despite bullish MACD
- RSI approaching overbought levels
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Low P/E and P/B relative to peers
- Sustainable 4.24% dividend yield
- Upside potential toward analyst median target
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Stable cash position and strong dividend policy
- Long‑term demographic demand for housing in Japan
- Undervalued valuation with modest growth outlook
Key Metrics & Analysis
Financial Health
Revenue Growth1.70%
Profit Margin6.11%
P/E Ratio8.8
ROE12.64%
ROA4.61%
Debt/Equity84.77
P/B Ratio1.1
Technical Analysis
TrendBearish
RSI66.7
Support¥3,202.00
Resistance¥3,512.00
MA 20¥3,316.55
MA 50¥3,347.20
MA 200¥3,447.86
MACDBullish
VolumeDecreasing
Fear & Greed Index93.2
Valuation
Target Price¥3,838.89
Upside/Downside9.71%
GradeUndervalued
TypeValue
Dividend Yield4.24%
Risk Assessment
Beta0.12
Volatility21.67%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.